pcDNA3-SARS-CoV-2-S-RBD-8his Citations (13)
Originally described in: Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, Herbert AS, Procko E Science. 2020 Sep 4;369(6508):1261-1265. doi: 10.1126/science.abc0870. Epub 2020 Aug 4. PubMed Journal
Articles Citing pcDNA3-SARS-CoV-2-S-RBD-8his
Showing 1 to 10 of 13 entries
| Articles |
|---|
Articles |
|---|
| Efficient Purification of Polyhistidine-Tagged Recombinant Proteins Using Functionalized Corundum Particles. Volzke JL, Smatty S, Doring S, Ewald S, Oelze M, Fratzke F, Flemig S, Konthur Z, Weller MG. BioTech (Basel). 2023 May 3;12(2):31. doi: 10.3390/biotech12020031. PubMed |
| Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination. Fertig TE, Chitoiu L, Marta DS, Ionescu VS, Cismasiu VB, Radu E, Angheluta G, Dobre M, Serbanescu A, Hinescu ME, Gherghiceanu M. Biomedicines. 2022 Jun 28;10(7):1538. doi: 10.3390/biomedicines10071538. PubMed |
| Maximization of the Minicircle DNA Vaccine Production Expressing SARS-CoV-2 RBD. Ventura C, Eusebio D, Goncalves AM, Barroca-Ferreira J, Costa D, Cui Z, Passarinha LA, Sousa A. Biomedicines. 2022 Apr 25;10(5):990. doi: 10.3390/biomedicines10050990. PubMed |
| A rapid bead-based assay for screening of SARS-CoV-2 neutralizing antibodies. Lupitha SS, Darvin P, Chandrasekharan A, Varadarajan SN, Divakaran SJ, Easwaran S, Nelson-Sathi S, Umasankar PK, Jones S, Joseph I, Pillai MR, Santhoshkumar TR. Antib Ther. 2022 Mar 17;5(2):100-110. doi: 10.1093/abt/tbac007. eCollection 2022 Apr. PubMed |
| An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2. Zhang L, Narayanan KK, Cooper L, Chan KK, Devlin CA, Aguhob A, Shirley K, Rong L, Rehman J, Malik AB, Procko E. bioRxiv. 2022 Mar 28. doi: 10.1101/2022.03.28.486075. PubMed |
| A Mycobacteriophage-Based Vaccine Platform: SARS-CoV-2 Antigen Expression and Display. Freeman KG, Wetzel KS, Zhang Y, Zack KM, Jacobs-Sera D, Walters SM, Barbeau DJ, McElroy AK, Williams JV, Hatfull GF. Microorganisms. 2021 Nov 23;9(12). pii: microorganisms9122414. doi: 10.3390/microorganisms9122414. PubMed |
| Sustained Delivery of SARS-CoV-2 RBD Subunit Vaccine Using a High Affinity Injectable Hydrogel Scaffold. Chen J, Wang B, Caserto JS, Shariati K, Cao P, Pan Y, Xu Q, Ma M. Adv Healthc Mater. 2022 Jan;11(2):e2101714. doi: 10.1002/adhm.202101714. Epub 2021 Nov 16. PubMed |
| Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction. Ahmad J, Jiang J, Boyd LF, Zeher A, Huang R, Xia D, Natarajan K, Margulies DH. J Biol Chem. 2021 Oct;297(4):101202. doi: 10.1016/j.jbc.2021.101202. Epub 2021 Sep 16. PubMed |
| Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar Affinity. Havranek B, Chan KK, Wu A, Procko E, Islam SM. J Chem Inf Model. 2021 Sep 27;61(9):4656-4669. doi: 10.1021/acs.jcim.1c00783. Epub 2021 Aug 24. PubMed |
| Structures of synthetic nanobody-SARS-CoV-2-RBD complexes reveal distinct sites of interaction and recognition of variants. Margulies D, Ahmad J, Jiang J, Boyd L, Zeher A, Huang R, Xia D, Natarajan K. Res Sq. 2021 Jun 16. doi: 10.21203/rs.3.rs-625642/v1. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.